Analysts Expect Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) to Post -$0.64 Earnings Per Share

Equities analysts expect that Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Rating) will post earnings of ($0.64) per share for the current quarter, Zacks Investment Research reports. Zero analysts have made estimates for Iovance Biotherapeutics’ earnings, with the highest EPS estimate coming in at ($0.59) and the lowest estimate coming in at ($0.73). Iovance Biotherapeutics reported […]

Related Keywords

Wellington ,New Zealand General ,New Zealand ,Blackrock ,Thomson Reuter ,Stifel Nicolaus ,Iovance Biotherapeutic ,Robertw Baird ,Iovance Biotherapeutics ,Zacks Investment Research ,Perceptive Advisors ,Wellington Management Group ,Blackrock Inc ,Nasdaq ,Iovance Biotherapeutics Inc ,Wells Fargo Company ,Farallon Capital Management ,Get Rating ,Management Group ,Capital Management ,State Street Corp ,Street Corp ,Nasdaq Iova ,Tiova ,Medical ,Ratings ,Consensus ,